Vanguard Capital Management’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Vanguard Capital Management's IRD Position: Q3 2026 in Review
Vanguard Capital Management increased its Opus Genetics (IRD) stake by 11% in Q3 2026, buying an estimated $1.31M and bringing the position to 3,273,451 shares worth $15.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2519.
Vanguard Capital Management first reported a position in IRD in Q1 2026 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Vanguard Capital Management held 3,273,451 shares of Opus Genetics worth $15.8M as of Q3 2026.
- Vanguard Capital Management bought 314,768 Opus Genetics shares in Q3 2026, an estimated $1.31M.
- Opus Genetics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2519 holding.
- Vanguard Capital Management first reported a position in Opus Genetics in Q1 2026 and has held it in 3 quarters since.
- 114 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.